Latest News
Impax assets under management narrow in fourth quarter
Investment firm Impax Asset Management reported a decrease in its assets under discretionary and advisory management (AUM) for the fourth quarter ended 30 September on Monday, while marking an annual increase.
Mind Gym FY profits seen 'significantly lower' than market expectations
Staff training firm Mind Gym warned that both full-year profits and revenue would be "significantly lower" than current market expectations.
London midday: Stocks maintain gains; BP, Shell boosted by surging oil prices
London stocks were still firmer by midday on Monday, with defence and energy shares pacing the advance, as oil prices surged amid tensions in the Middle East.
US pre-open: Middle East conflict to hit markets early as oil prices jump
US stocks were expected to fall on Monday, reversing much of the gains made the previous session, on the back of heightened geopolitical tensions in the Middle East.
Eurozone investor sentiment falls less than expected
Eurozone investor sentiment deteriorated less than expected in October, according to data released on Monday.
Chaarat Gold CEO steps down
Exploration and development company Chaarat Gold revealed on Monday that chief executive Mike Fraser would be stepping down as a director of the company.
JPMorgan places Next, AB Foods on 'negative catalyst watch'
JPMorgan Cazenove placed the shares of Next and Primark owner Associated British Foods on ‘negative catalyst watch’ on Monday as it took a look at the European general retail sector.
Volex hit by cyber attack, no material financial impact expected
Volex said on Monday that it had been hit by a cyber attack but insisted there would be no material financial impact.
Assura delivers strong H1 performance, ups RCF
Primary care property business Assura said on Monday that it had delivered a strong interim performance.
Asia report: Markets mixed with retail sales, oil prices in focus
Asia-Pacific markets were mixed on Monday at the beginning of the week, with Chinese markets resuming trade after the Golden Week holiday.
Europe open: Stocks rattled by Israel conflict as oil prices surge
Stocks across Europe mostly declined on Monday as oil prices surged on geopolitical uncertainty following the weekend attack on Israel.
Croda cuts full-year profit outlook
Specialty chemicals company Croda cut its full-year profit outlook on Monday following a weaker-than-expected third-quarter performance.
Metro Bank announces £925m capital package, looking at mortgage sale
Metro Bank announced a robust capital and debt restructuring package totalling £925m on Monday, after a week of market chatter and reports around its capital position, although some current stakeholders will be taking a 40% haircut.
Chill Brands surges on WHSmith vape deal
Chill Brands surged on Monday as it announced the sale of its Chill ZERO nicotine-free vapour products into WHSmith stores.
LXI Reit sees valuations fall, but 'green shots' emerging
UK real estate investment trust LXI Reit has said it is seeing "green shoots emerging" after a tough macro environment led to another drop in valuations across its portfolio.
London open: Stocks rise as oil prices surge on Middle East tensions
London stocks rose in early trade on Monday, with defence and energy shares pacing the advance, as oil prices surged amid tensions in the Middle East.
ScS confident in results despite announcing brief delay
ScS Group announced a brief delay to its full-year results for the 52 weeks ended 29 July on Monday, now slated for 25 October instead of the initially expected 10 October.
Bodycote spends $145m to further expand US footprint
Thermal processing services group Bodycote has announced it is spending $145m on two specialist tech companies and opening a new facility to expand its reach in North America.
German industrial production falls again in August
German industrial production fell in August for the fourth month in a row, according to data released on Monday by Destatis.
GSK inks deal to promote shingles vaccine in China
GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2. 5bn over the next three years.